BIOLIFE SOLUTIONS INC

BLFS

Form 4 • Statement of Changes in Beneficial Ownership

SEC Accession Number: 0001628280-26-015339
Filing date: Mar 5, 2026
Earliest execution date: Mar 3, 2026
Reporting Owners: Wichterman Troy (CFO)
SEC Filing link

Summary

Type

Sell

Net shares

-588

% of shares

-0.27%

Amount (USD)

$12,195

Insider confidence score

51.9 out of 100

Positive

  • Under Rule 10b5-1 trading plan
  • Small scheduled sell (<0.5% of shares)
  • Small sell amount (<$50K)

Stock transactions

Transaction 1

Security

Common Stock

Action

Sell

Date

2026-03-03

Code

S

Net shares

-588.0

Price per Share

$20.74

Amount (USD)

$12,195.12

Acquired/Disposed

Disposed

Shares Owned Before

221,237.0

Shares Owned After

220,649.0

Filing's footnotes

1. The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

ℹ️ Filed under Rule 10b5-1 trading plan

This page is for informational purposes only. While we strive for accuracy, the summary may contain inaccuracies or omissions. Please refer to the official SEC filing for authoritative information. Open the SEC filing.